In a recent essay, scientists challenge the prevailing genetic-focused model of cancer, advocating for a shift towards more ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Overriding the "Off Switch" Cells function through an intricate network of proteins, each designed for specific tasks like ...

The connection between sugar and cancer, including whether you need to give up your favorite sweet bites to stave off cancer.

Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, ...

THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

Elevation Oncology discontinues EO-3021 for gastric and gastroesophageal junction cancers after phase 1 trial shows ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...